Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8226-8233

  Zhu, Lingqiao ^a   Ji, Fang ^a   Wang, Yuan ^a   Zhang, Yi ^b   Liu, Qiang ^a   Zhang, Jingwu Z ^a,c   Matsushima, Kouji ^d   Cao, Qi ^a   Zhang, Yanyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL DEXTRO TRYPTOPHAN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; MONOCLONAL ANTIBODY; TRYPTOPHAN; TRYPTOPHAN TRANSFER RNA LIGASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STORAGE; SYNOVIAL FLUID; SYNOVIOCYTE; T LYMPHOCYTE;

EID: 33751574468     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8226     Document Type: Article

References (51)

1. Smolen, J. S., and G. Steiner. 2003. Therapeutic strategies for rheumatoid arthritis. Nat. Rev. Drug Discov. 2: 473-488.
2. Santiago-Schwarz, F., P. Anand, S. Liu, and S. E. Carsons. 2001. Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses. J. Immunol. 167: 1758-1768.
3. Firestein, G. S., and N. J. Zvaifler. 1990. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33: 768-733.
4. dim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum. 35: 1455-1465.
5. Panayi, G. S., J. S. Lanchbury, and G. H. Kingsley. 1992. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35: 729-735.
6. - memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 39: 844-854.
7. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation and maintenance. Annu. Rev. Immunol. 22: 745-763.
8. Mima, T., Y. Saeki, S. Ohshima, N. Nishimoto, M. Matsushita, M. Shimizu, Y. Kobayashi, T. Nomura, and T. Kishimoto. 1995. Transfer of rheumatoid arthritis into severe combined immunodeficient mice. J. Clin. Invest. 96: 1746-1758.
9. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363-1372.
10. Mellor, A. L., D. B. Keskin, T. Johnson, P. Chandler, and D. H. Munn. 2002. Cells expressing indoleamine 2,3 dioxygenase inhibit T cell responses. J. Immunol. 168: 3771-3776.
11. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870.
12. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172: 4100-4110.
13. Odemuyiwa, S. O., A. Ghahary, Y. Li, L. Puttagunta, J. E. Lee, S. Musat-Marcu, A. Ghahary, and R. Moqbel. 2004. Human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J. Immunol. 173: 5909-5913.
14. Meisel, R., A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
15. + hematopoietic progenitor cells. Blood 95: 138-146.
16. Hayashi, T., L. Beck, C. Rossetto, X. Gong, O. Takikawa, K. Takabayashi, D. H. Broide, D. A. Carson, and E. Raz. 2004. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114: 270-279.
17. Friberg, M., R. Jennings, M. Alsarraj, S. Dessureault, A. Cantor, M. Extermann, A. L. Mellor, D. H. Munn, and S. J. Antonia. 2002. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 101: 151-155.
18. Uyttenhove, C., L. Pilotte, I. Theate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B. J. Van den Eynde. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9: 1269-1274.
19. Munn, D. H., M. D. Sharma, D. Hou, B. Baban, J. R. Lee, S. J. Antonia, J. L. Messina, P. Chandler, P. A. Koni, and A. L. Mellor. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor draining lymph nodes. J. Clin. Invest. 114: 280-290.
20. Grohmann, U., F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. C. Fioretti, and P. Puccetti. 2003. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198: 153-160.
21. Fleckner, J., P. M. Martensen, A. B. Tolstrup, N. O. Kjeldgaard, and J. Justesen. 1995. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7: 70-77.
22. Murray, M. F. 2003. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect. Dis. 3: 644-652.
23. + T cells. Blood 105: 1574-1581.
24. Summers, K. L., J. L. O'Donnell, A. Heiser, J. Highton, and D. N. Hart. 1999. Synovial fluid transforming growth factor β inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis. Arthritis Rheum. 42: 507-518.
25. Widner, B., E. R. Werner, H. Schennach, H. Wachter, and D. Fuchs. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43: 2424-2426.
26. Xu, G., H. Nie, N. Li, W. Zheng, D. Zhang, G. Feng, L. Ni, R. Xu, J. Hong, and J. Z. Zhang. 2005. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J. Clin. Invest. 115: 1060-1067.
27. Grohmann, U., F. Fallarino, and P. Puccetti. 2003. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24: 242-248.
28. Mellor, A. L., and D. H. Munn. 1999. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 20: 469-473.
29. Frumento, G., R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B. Ferrara. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196: 459-468.
30. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
31. Shortman, K., and W. R. Heath. 2001. Immunity or tolerance? That is the question for dendritic cells. Nat. Immunol. 2: 988-989.
32. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358.
33. Finger, E. B., and J. A. Bluestone. 2002. When ligand becomes receptor-tolerance via B7 signaling on DCs. Nat. Immunol. 3: 1056-1057.
34. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
35. Steinman, R. M. 2003. The control of immunity and tolerance by dendritic cell. Pathol. Biol. 51: 59-60.
36. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
37. Mellor, A. L., B. Baban, P. Chandler, B. Marshall, K. Jhaver, A. Hansen, P. A. Koni, M. Iwashima, and D. H. Munn. 2003. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171: 1652-1655.
38. Sakurai, K., J. P. Zou, J. R. Tschetter, J. M. Ward, and G. M. Shearer. 2002. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 129: 186-196.
39. Gurtner, G. J., R. D. Newberry, S. R. Schloemann, K. G. McDonald, and W. F. Stenson. 2003. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125: 1762-1773.
40. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
41. Kudo, Y., and C. A. Boyd. 2001. Characterization of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles. J. Physiol. 531: 405-416.
42. Kudo, Y., and C. A. Boyd. 2000. Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim. Biophys. Acta 1500: 119-124.
43. Praetorius-Ibba, M., N. Stange-Thomann, M. Kitabatake, K. Ali, I. Soll, C. W. Carter, Jr., M. Ibba, and D. Soll. 2000. Ancient adaptation of the active site of tryptophanyl-tRNA synthetase for tryptophan binding. Biochemistry 39: 13136-13141.
44. Terness, P., T. M. Bauer, L. Röse, C. Dufter, A. Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196: 447-457.
45. Rubin, B. Y., S. L. Anderson, L. Xing, R. J. Powell, and W. P. Tate. 1991. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266: 24245-24248.
46. Strehlow, I., D. Seegert, C. Frick, F. C. Bange, C. Schindler, E. C. Bottger, and T. Decker. 1993. The gene encoding IFP 53/tryptophanyl-tRNA synthetase is regulated by the γ-interferon activation factor. J. Biol. Chem. 268: 16590-16595.
47. Tolstrup, A. B., A. Bejder, J. Fleckner, and J. Justesen. 1995. Transcriptional regulation of the interferon-γ-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J. Biol. Chem. 270: 397-403.
48. Jorgensen, R., T. M. Sogaard, A. B. Rossing, P. M. Martensen, and J. Justesen. 2000. Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J. Biol. Chem. 275: 16820-16826.
49. Yuan, W., A. Collado-Hidalgo, T. Yufit, M. Taylor, and J. Varga. 1998. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-β: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J. Cell. Physiol. 177: 174-186.
50. Frolova, L. Y., A. Y. Grigorieva, M. A. Sudomoina, and L. L. Kisselev. 1993. The human gene encoding tryptophanyl-tRNA synthetase: interferon-response elements and exon-intron organization. Gene 128: 237-245.
51. Fleckner, J., H. H. Rasmussen, and J. Justesen. 1991. Human interferon-γ potently induces the synthesis of a 55-kDa protein (γ2) highly homologous to rabbit peptide chain release factor and bovine tryptophanyl-tRNA synthetase. Proc. Natl. Acad. Sci. USA 88: 11520-11524.